Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine
+ T cell experiment, for which a few similar studies have shown the same result, can be further explored by using additional markers to distinguish the smaller groups of T cells and observe their apoptosis ratio (Sha et al., 2024)
We report that in obese mice, GLP-1 medicines predominantly reduce body fat alongside a small but significant decrease in LBM
The results are fascinating, but they come with some major red flags that every clinician needs to hear before their next patient interaction
"No one ever said anything to me, but I was like, I'm the pot calling the kettle black here," she said
Lets pursue more information and a guide to semaglutide for weight loss